Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 6,410.00
-110.00 (-1.69%)
Feb 27, 2026, 3:30 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 295.16 billion as of February 27, 2026. Its market cap has increased by 152.86% in one year.
Market Cap
295.16B
Enterprise Value
212.84B
Revenue
3.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,410.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has increased from 238.64B to 295.16B, an increase of 23.68%. That is a compound annual growth rate of 1.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 295.16B | 3.05% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BINEX | 475.49B |
| GC Cell | 380.19B |
| JETEMA, | 367.25B |
| Anterogen.Co.,Ltd. | 359.72B |
| Bioneer | 320.31B |
| EASY BIO,Inc. | 243.15B |
| HLB Therapeutics | 235.50B |
| Vaxcell-Bio Therapeutics | 215.83B |